Your browser doesn't support javascript.
loading
Why Do ACG and AGA Guidelines Differ for the Use of Probiotics and the Prevention of CDI?
McFarland, Lynne V; Kullar, Ravina; Johnson, Stuart; Sniffen, Jason C; Woolard, Kristin; Goldstein, Ellie J C.
Affiliation
  • McFarland LV; University of Washington, Seattle, Washington, USA.
  • Kullar R; Expert Stewardship, Inc., Newport Beach, California, USA.
  • Johnson S; Hines VA Hospital and Loyola University Medical Center, Chicago, Illinois, USA.
  • Sniffen JC; Infectious Disease Consultants and AdventHealth Orlando, Orlando, Florida, USA.
  • Woolard K; Infectious Disease Consultants and AdventHealth Orlando, Orlando, Florida, USA.
  • Goldstein EJC; RM Alden Research Laboratory and the David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Am J Gastroenterol ; 117(3): 501, 2022 03 01.
Article in En | MEDLINE | ID: mdl-35020606
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clostridioides difficile / Clostridium Infections / Probiotics Type of study: Guideline Limits: Humans Language: En Journal: Am J Gastroenterol Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clostridioides difficile / Clostridium Infections / Probiotics Type of study: Guideline Limits: Humans Language: En Journal: Am J Gastroenterol Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos